205 related articles for article (PubMed ID: 7403524)
1. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
Tonami N; Hisada K
Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
[TBL] [Abstract][Full Text] [Related]
2. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
3. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
Oyen WJ; Verhagen C; Saris E; van den Broek WJ; Pieters GF; Corsten FH
J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
[TBL] [Abstract][Full Text] [Related]
4. Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.
Iida Y; Hidaka A; Hatabu H; Kasagi K; Konishi J
J Nucl Med; 1991 Nov; 32(11):2098-100. PubMed ID: 1941144
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.
Nakahara H; Noguchi S; Murakami N; Hoshi H; Jinnouchi S; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
J Nucl Med; 1996 Jun; 37(6):901-4. PubMed ID: 8683308
[TBL] [Abstract][Full Text] [Related]
6. Relationship among 201T1 uptake, nuclear DNA content and clinical behavior in metastatic thyroid carcinoma.
Nakada K; Katoh C; Morita K; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Tamaki N
J Nucl Med; 1999 Jun; 40(6):963-7. PubMed ID: 10452311
[TBL] [Abstract][Full Text] [Related]
7. Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy.
Arnstein NB; Juni JE; Sisson JC; Lloyd RV; Thompson NW
J Nucl Med; 1986 Oct; 27(10):1564-8. PubMed ID: 3760981
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
9. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
[TBL] [Abstract][Full Text] [Related]
10. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ
J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
Balon HR; Fink-BennetT D; Stoffer SS
J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
[TBL] [Abstract][Full Text] [Related]
12. [Thyroglobulin as a tumor marker and thallium scintigraphy for the course control of differentiated thyroid cancer].
Müller-Brand J; Fridrich R; Spicher E; Staub JJ
Schweiz Med Wochenschr; 1983 Mar; 113(9):325-7. PubMed ID: 6844904
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan.
Kaya M; Cermik TF
Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510
[TBL] [Abstract][Full Text] [Related]
14. Localization of residual medullary thyroid cancer by thallium/technetium scintigraphy.
Talpos GB; Jackson CE; Froelich JW; Kambouris AA; Block MA; Tashjian AH
Surgery; 1985 Dec; 98(6):1189-96. PubMed ID: 2866591
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
Miyamoto S; Kasagi K; Misaki T; Alam MS; Konishi J
J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphy with 201Tl for detection of thyroid cancer metastases.
Piers DA; Sluiter WJ; Willemse PH; Doorenbos H
Eur J Nucl Med; 1982; 7(11):515-7. PubMed ID: 7173250
[TBL] [Abstract][Full Text] [Related]
17. Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules: usefulness of the delayed scan.
Ochi H; Sawa H; Fukuda T; Inoue Y; Nakajima H; Masuda Y; Okamura T; Onoyama Y; Sugano S; Ohkita H; Tei Y; Kamino K; Kobayashi Y
Cancer; 1982 Jul; 50(2):236-40. PubMed ID: 7083130
[TBL] [Abstract][Full Text] [Related]
18. [Iodine scintigraphy of differentiated thyroid carcinoma].
Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
[No Abstract] [Full Text] [Related]
19. Management of patients with thyroid carcinoma: application of thallium-201 scintigraphy and magnetic resonance imaging.
Burman KD; Anderson JH; Wartofsky L; Mong DP; Jelinek JJ
J Nucl Med; 1990 Dec; 31(12):1958-64. PubMed ID: 2266393
[TBL] [Abstract][Full Text] [Related]
20. [Value of posttherapeutic scintigraphy for the demonstration of distant metastases of differentiated carcinomas of the thyroid gland].
Moser E; Hahn D; Wendt T; Büll U
Strahlentherapie; 1983 Apr; 159(4):217-23. PubMed ID: 6857735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
